Healthcare -
Biotechnology - NASDAQ - US
$ 5.89
0.684 %
$ 252 M
Market Cap
-10.52
P/E
Price Target
Average
41.48%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
3.19%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
DiaMedica Therapeutics Inc.
Wall Street analysts predict an average 1-year price target for DMAC of $8.33 , with forecasts ranging from
a
low of
$7 to a high of $10 .
DMAC Lowest Price Target
Wall Street Target
7 USD
18.85%
DMAC Average Price Target
Wall Street Target
8.33 USD
41.48%
DMAC Highest Price Target
Wall Street Target
10 USD
69.78%
REVENUE FORECAST
Revenue Forecast Chart DMAC
EBIT FORECAST
EBIT Forecast Chart DMAC
NET INCOME FORECAST
Net Income Chart DMAC